Literature DB >> 1592452

Pressor responsiveness in corticosteroid-induced hypertension in humans.

M Pirpiris1, K Sudhir, S Yeung, G Jennings, J A Whitworth.   

Abstract

In previous studies short-term cortisol increased cold pressor responses and the rise in forearm vascular resistance accompanying intra-arterial norepinephrine without an increase in overall resting sympathetic nervous activity. The present study examined whether these alterations in pressor response are glucocorticoid or mineralocorticoid effects, or both. Normal male subjects (n = 12) received either fludrocortisone, 0.3 mg daily (n = 6), or dexamethasone, 3 mg daily (n = 6), for 7 days. Hemodynamic studies were performed before and on day 7 of treatment. Fludrocortisone increased body weight from 69.3 +/- 1.8 to 71.1 +/- 2 kg (p less than 0.001), cardiac output from 5.0 to 6.0 l/min (+/- 0.1, p less than 0.01), mean arterial pressure from 82 +/- 1 to 91 +/- 1 mm Hg (p less than 0.001), cold pressor responsiveness from 13.0 to 39.0 mm Hg/ml per 100 ml per minute (R units) (+/- 4.3, p less than 0.01), and forearm vascular response to intra-arterial norepinephrine (F = 59.4, p less than 0.01) and angiotensin II (F = 30.8, p less than 0.01) infusions. Total peripheral resistance fell from 22.0 to 20.1 mm Hg/l per minute (+/- 0.3, p less than 0.05). Dexamethasone did not increase cardiac output, 5.1 to 5.2 l/min (+/- 0.1), or body weight but did increase mean arterial pressure from 82 +/- 3 to 91 +/- 3 mm Hg (p less than 0.001), cold pressor responsiveness from 8.6 to 17.1 R units (+/- 2.8, p less than 0.05), and forearm vascular response to intra-arterial norepinephrine (F = 33.0, p less than 0.01) and angiotensin II (F = 54.9, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592452     DOI: 10.1161/01.hyp.19.6.567

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  The effect of intrafetal infusion of metyrapone on arterial blood pressure and on the arterial blood pressure response to angiotensin II in the sheep fetus during late gestation.

Authors:  K E Warnes; C L Coulter; J S Robinson; I C McMillen
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

2.  Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.

Authors:  J A Whitworth; J J Kelly
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

3.  Physiologic responses to severe hemorrhagic shock and the genesis of cardiovascular collapse: can irreversibility be anticipated?

Authors:  Hernando Gómez; Jaume Mesquida; Linda Hermus; Patricio Polanco; Hyung Kook Kim; Sven Zenker; Andrés Torres; Rajaie Namas; Yoram Vodovotz; Gilles Clermont; Juan Carlos Puyana; Michael R Pinsky
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

4.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  Glucocorticoid therapy for hypotension in the cardiac intensive care unit.

Authors:  K J Millar; R R Thiagarajan; P C Laussen
Journal:  Pediatr Cardiol       Date:  2007-03-20       Impact factor: 1.655

6.  Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats.

Authors:  Emilio A Herrera; Misha M Verkerk; Jan B Derks; Dino A Giussani
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

Review 7.  [Glucocorticoids and hypertension].

Authors:  C Dodt; J P Wellhöner; M Schütt; F Sayk
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

8.  The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy.

Authors:  O T Eipel; K Németh; D Török; K Csordás; M Hegyi; A Ponyi; A Ferenczy; D J Erdélyi; M Csóka; G T Kovács
Journal:  Int J Hematol       Date:  2013-01-26       Impact factor: 2.490

9.  Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease.

Authors:  Sherif Hanafy; Maury Pinsk; Fakhreddin Jamali
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

10.  Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study.

Authors:  Nikolaos Tzemos; Pitt O Lim; Thomas M MacDonald
Journal:  Cardiovasc Ther       Date:  2009-07-14       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.